Casciaro, Rosaria
 Distribuzione geografica
Continente #
EU - Europa 583
AS - Asia 142
NA - Nord America 127
SA - Sud America 10
AF - Africa 3
OC - Oceania 1
Totale 866
Nazione #
IT - Italia 570
US - Stati Uniti d'America 119
SG - Singapore 52
CN - Cina 38
VN - Vietnam 25
BD - Bangladesh 10
HK - Hong Kong 9
BR - Brasile 8
CA - Canada 6
JP - Giappone 3
AR - Argentina 2
ES - Italia 2
ID - Indonesia 2
IN - India 2
NL - Olanda 2
UA - Ucraina 2
AU - Australia 1
CR - Costa Rica 1
DE - Germania 1
ET - Etiopia 1
FR - Francia 1
GB - Regno Unito 1
IE - Irlanda 1
MA - Marocco 1
MX - Messico 1
NG - Nigeria 1
PL - Polonia 1
RO - Romania 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
Totale 866
Città #
Genoa 398
Vado Ligure 83
San Jose 43
Rapallo 41
Genova 28
Singapore 23
Ho Chi Minh City 10
Hong Kong 9
New York 9
Ashburn 7
Beijing 7
Hanoi 5
Milan 4
Montreal 3
Santa Clara 3
Tokyo 3
Amsterdam 2
Charlotte 2
Council Bluffs 2
Dallas 2
Denver 2
Haiphong 2
Los Angeles 2
Madrid 2
Orem 2
Queens 2
Rome 2
San Diego 2
Sinnai 2
Addis Ababa 1
Albuquerque 1
Atlanta 1
Baiano 1
Banyuwangi 1
Betim 1
Biên Hòa 1
Brandon 1
Brescia 1
Brooklyn 1
Buffalo 1
Caraguatatuba 1
Chehalis 1
Cleveland 1
Conselheiro Lafaiete 1
Da Nang 1
Dammam 1
Dixon 1
Dublin 1
Edison 1
Elizabeth 1
Fes 1
Francisco Beltrão 1
Frankfurt am Main 1
Garibaldi 1
Gobernador Virasoro 1
Hải Dương 1
Itabuna 1
Las Vegas 1
Lauterbourg 1
London 1
Marnate 1
Mexico City 1
Middletown 1
Milwaukee 1
Mineiros 1
Morristown 1
Naples 1
Newark 1
Ninh Bình 1
Parkland 1
Pasadena 1
Phoenix 1
Phúc Yên 1
Piscataway 1
Ploieşti 1
Recanati 1
Roccalumera 1
San Francisco 1
San José 1
Santa Maria la Longa 1
Shanghai 1
Sousa 1
Spoltore 1
Stockton 1
Sydney 1
Temecula 1
Thái Bình 1
Toronto 1
Turiisk 1
Turin 1
Tân Tiến 1
Udaipur 1
Verona 1
Vigodarzere 1
Virginia Beach 1
Warsaw 1
Totale 769
Nome #
A case of interference in testosterone, DHEA-S and progesterone measurements by second generation immunoassays 148
Mental health and cystic fibrosis: Time to move from secondary prevention to predictive medicine 114
A Novel LC-MS/MS Method for the Measurement of Elexacaftor, Tezacaftor and Ivacaftor in Plasma, Dried Plasma Spot (DPS) and Whole Blood in Volumetric Absorptive Microsampling (VAMS) Devices 92
Simultaneous Quantification of Ivacaftor, Tezacaftor, and Elexacaftor in Cystic Fibrosis Patients’ Plasma by a Novel LC–MS/MS Method 89
Generation of an induced pluripotent stem cell line (IGGi002A) from nasal cells of a cystic fibrosis patient homozygous for the G542X-CFTR mutation 82
Efficacy of advanced hybrid closed loop systems in cystic fibrosis related diabetes: a pilot study 81
Therapeutic monitoring of Ivacaftor, Tezacaftor and Elexacaftor in patients with cystic fibrosis|Monitoraggio terapeutico di Ivacaftor, Tezacaftor e Elexacaftor in pazienti con fibrosi cistica 74
QUANTIFICATION OF IVACAFTOR, TEZACAFTOR, AND ELEXACAFTOR IN PLASMA OF CYSTIC FIBROSIS PATIENTS BY AN HPLC–MS/MS METHOD 72
Quantification of Ivacaftor, Tezacaftor and Elexacaftor in plasma of cystic fibrosis patients treated with Kaftrio by a validated liquid chromatography-tandem mass spectrometric (LC-MS/MS) method” 67
One-Year Effect of Elexacaftor/Tezacaftor/Ivacaftor Therapy on HbA1c Levels and Insulin Requirement in Patients with Insulin-Dependent Cystic Fibrosis-Related Diabetes: A Retrospective Observational Study 61
Totale 880
Categoria #
all - tutte 3.065
article - articoli 2.583
book - libri 0
conference - conferenze 482
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.130


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202214 0 0 0 0 1 2 0 4 1 3 0 3
2022/202346 2 4 0 5 2 7 0 7 14 0 5 0
2023/202456 1 4 1 5 6 11 7 2 6 3 4 6
2024/2025306 8 22 10 9 15 27 11 68 30 30 39 37
2025/2026442 70 15 26 31 59 18 61 17 38 31 57 19
Totale 880